490 related articles for article (PubMed ID: 15204706)
1. Combined gamma-irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin.
Caney C; Singh G; Lukka H; Rainbow AJ
Int J Radiat Biol; 2004 Apr; 80(4):291-9. PubMed ID: 15204706
[TBL] [Abstract][Full Text] [Related]
2. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
[TBL] [Abstract][Full Text] [Related]
3. Pre-exposure of human squamous carcinoma cells to low-doses of gamma-rays leads to an increased resistance to subsequent low-dose cisplatin treatment.
Caney C; Bulmer JT; Singh G; Lukka H; Rainbow AJ
Int J Radiat Biol; 1999 Aug; 75(8):963-72. PubMed ID: 10465362
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
Teicher BA; Holden SA; Kelley MJ; Shea TC; Cucchi CA; Rosowsky A; Henner WD; Frei E
Cancer Res; 1987 Jan; 47(2):388-93. PubMed ID: 3539321
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
6. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures.
Mitchell CR; Joiner MC
Int J Radiat Biol; 2002 Nov; 78(11):981-90. PubMed ID: 12456285
[TBL] [Abstract][Full Text] [Related]
7. Synergism between cisplatin and radiotherapy in an in vitro prostate tumor cell line.
Geldof AA; Kruit A; Newling DW; Slotman BJ
Anticancer Res; 1999; 19(1A):505-8. PubMed ID: 10226589
[TBL] [Abstract][Full Text] [Related]
8. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
[TBL] [Abstract][Full Text] [Related]
9. Radiosensitization of tumour cells by cantharidin and some analogues.
Price WA; Stobbe CC; Park SJ; Chapman JD
Int J Radiat Biol; 2004 Apr; 80(4):269-79. PubMed ID: 15204704
[TBL] [Abstract][Full Text] [Related]
10. CRABP I expression and the mediation of the sensitivity of human tumour cells to retinoic acid and irradiation.
Blaese MA; Santo-Hoeltje L; Rodemann HP
Int J Radiat Biol; 2003 Dec; 79(12):981-91. PubMed ID: 14713576
[TBL] [Abstract][Full Text] [Related]
11. Irradiation and various cytotoxic drugs enhance tyrosine phosphorylation and beta(1)-integrin clustering in human A549 lung cancer cells in a substratum-dependent manner in vitro.
Cordes N; Beinke C; Plasswilm L; van Beuningen D
Strahlenther Onkol; 2004 Mar; 180(3):157-64. PubMed ID: 14991204
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide radiosensitization of normal murine hematopoietic but not squamous cell carcinoma or multiple myeloma tumor cell lines.
Epperly MW; Greenberger EE; Franicola D; Jacobs S; Greenberger JS
In Vivo; 2006; 20(3):333-9. PubMed ID: 16724666
[TBL] [Abstract][Full Text] [Related]
13. [Cytotoxicity of pentoxifylline and its effect on human hepatoma cell line Hep3b radiosensitivity].
Wu DH; Liu L; Chen LH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):305-7. PubMed ID: 16546733
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitivity in multidrug-resistant and cisplatin-resistant human carcinoma cell lines.
Gigante M; Toffoli G; Bertola A; Biscontin G; Dassie A; Zanelli GD; Zanin E; Trovò MG; Muzzio PC
Am J Clin Oncol; 2003 Aug; 26(4):e73-9. PubMed ID: 12902902
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line.
Siler DF; Wheeless CR; Dubin NH
Cancer; 1996 May; 77(9):1850-3. PubMed ID: 8646684
[TBL] [Abstract][Full Text] [Related]
17. Clonal variability of radiation-induced cisplatin resistant HeLa cells.
Eichholtz-Wirth H; Marx K
Anticancer Res; 1998; 18(4C):2989-91. PubMed ID: 9713497
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor.
Mandic R; Rodgarkia-Dara CJ; Krohn V; Wiegand S; Grénman R; Werner JA
Anticancer Res; 2009 Apr; 29(4):1181-7. PubMed ID: 19414362
[TBL] [Abstract][Full Text] [Related]
19. Curcumin: a new radio-sensitizer of squamous cell carcinoma cells.
Khafif A; Hurst R; Kyker K; Fliss DM; Gil Z; Medina JE
Otolaryngol Head Neck Surg; 2005 Feb; 132(2):317-21. PubMed ID: 15692547
[TBL] [Abstract][Full Text] [Related]
20. Effects of cisplatin and gamma-irradiation on cell survival, the induction of chromosomal aberrations and apoptosis in SW-1573 cells.
Bergs JW; Franken NA; ten Cate R; van Bree C; Haveman J
Mutat Res; 2006 Feb; 594(1-2):148-54. PubMed ID: 16202432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
